US 11865134
Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors
granted A61KA61K31/573A61K31/713
Quick answer
US patent 11865134 (Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/573, A61K31/713, A61K45/06, A61P